Suraksha Diagnostic IPO GMP History
Suraksha Diagnostic IPO has been listed on December 6, 2024 at a listing price of ₹438, against the issue price of ₹441 — a loss of ₹3 (-0.68%). The GMP peaked at ₹12 on 5 December 2024 and reached a low of ₹10 on 4 December 2024. The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.
Suraksha Diagnostic IPO raised ₹846.25 Cr. through its IPO at a price band of ₹420 to ₹441 per share, with a lot size of 34 shares. The IPO was open for subscription from 29 Nov 2024 to 03 Dec 2024.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
GMP trend
Grey market premium sampled three times a day (11 AM, 5 PM, 10 PM). Last updated 10 Nov, 11:30 PM IST.
Day-wise GMP
The last reading of each day, newest first. Arrows compare with the previous day.
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| 05 Dec 2024 | ₹ 12 | ▲ | 3% | — | — |
| 04 Dec 2024 | ₹ 10 | — | 2% | — | — |
Suraksha Diagnostic IPO dates
Key dates from opening to listing. Today is 11 November.
- Open 29 Nov 2024
- Close 03 Dec 2024
- Allotment 04 Dec 2024
- Refund/credit 05 Dec 2024
- Listing 06 Dec 2024
Suraksha Diagnostic IPO actual listing price
How the grey market's final call compared with the listing-day open.
| Issue price | ₹441 |
|---|---|
| GMP-based estimate (pre-listing) | ₹453 (+2.7%) |
| Listing gain / loss | −₹3 per share |
| Listing date | 06 Dec, 2024 |
| Actual listing price | ₹438 (-0.68%) |
Is Suraksha Diagnostic IPO GMP reliable?
Grey market premium for Suraksha Diagnostic IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- 01Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- 02Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- 03Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- 04Cross-check before acting: Review the Suraksha Diagnostic IPO full review for a fundamentals-based assessment before making any grey market trades.
Suraksha Diagnostic IPO Kostak rate explained
Two ways the grey market trades an IPO application before listing.
The Kostak rate for Suraksha Diagnostic IPO was not available during the subscription period. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price was not available for this IPO. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About Suraksha Diagnostic IPO
Suraksha Diagnostic Limited was incorporated as Suraksha Diagnostic Private Limited at Kolkata on 15 March 2005. It offers one-stop integrated pathology and radiology testing and medical consultation services.
Its services include X-rays, ultrasonography, CT, MRI and vaccinations, through a central reference laboratory, 8 satellite laboratories and 215 customer touchpoints, including 49 diagnostic centres and 166 sample collection centres, as of 30 June 2024.
Its promoters are Somnath Chatterjee, Ritu Mittal and Satish Kumar Verma.
The IPO was Rs 846.25 crore and was entirely an offer for sale by the three promoters and investors, so the company received none of the money.
Frequently asked
What is the GMP of Suraksha Diagnostic IPO?
The current Grey Market Premium (GMP) of Suraksha Diagnostic IPO is ₹ 12.
What is the Kostak Price of Suraksha Diagnostic IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Suraksha Diagnostic IPO is not available.
What is the Subject to Sauda Price of Suraksha Diagnostic IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is not available.
What was the actual listing price of Suraksha Diagnostic IPO?
Suraksha Diagnostic IPO listed on December 6, 2024 at ₹438, against the issue price of ₹441 — a loss of -0.68%.
How did the GMP of Suraksha Diagnostic IPO trend before listing?
The GMP of Suraksha Diagnostic IPO was rising in its final days before listing. The GMP peaked at ₹12 on 5 December 2024. View the day-wise table above for the complete GMP history.
Explore Suraksha Diagnostic IPO further
The grey market is one signal. Read it alongside the demand, the reviews and the filings before you decide.
It has listed — go back to the fundamentals.
Category-wise demand from QIB, NII and retail investors, updated through the day.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
The grey market called it. Now check the fundamentals.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Read the grey market alongside the subscription book and the offer document before you apply.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
